View in EDS PDF Full Text

177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy.

Saved in:
Bibliographic Details
Title: 177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy.
Authors: John N; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Pathmanandavel S; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Crumbaker M; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia., Counter W; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Ho B; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Yam AO; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia., Wilson P; MIM Software, Inc., Cleveland, Ohio; and., Niman R; MIM Software, Inc., Cleveland, Ohio; and., Ayers M; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Poole A; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Hickey A; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Agrawal S; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Perkins G; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Kallinen A; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Eslick E; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia., Stockler MR; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia., Joshua AM; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia., Nguyen A; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia., Emmett L; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia; louise.emmett@svha.org.au.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2023 Mar; Vol. 64 (3), pp. 410-415. Date of Electronic Publication: 2022 Sep 08.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36215568
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: <superscript>177</superscript>Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing <superscript>177</superscript>Lu-PSMA-I&T Therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22John+N%22">John N</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Pathmanandavel+S%22">Pathmanandavel S</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Crumbaker+M%22">Crumbaker M</searchLink>; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Counter+W%22">Counter W</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Ho+B%22">Ho B</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Yam+AO%22">Yam AO</searchLink>; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Wilson+P%22">Wilson P</searchLink>; MIM Software, Inc., Cleveland, Ohio; and.<br /><searchLink fieldCode="AU" term="%22Niman+R%22">Niman R</searchLink>; MIM Software, Inc., Cleveland, Ohio; and.<br /><searchLink fieldCode="AU" term="%22Ayers+M%22">Ayers M</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Poole+A%22">Poole A</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Hickey+A%22">Hickey A</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Agrawal+S%22">Agrawal S</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Perkins+G%22">Perkins G</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Kallinen+A%22">Kallinen A</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Eslick+E%22">Eslick E</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Stockler+MR%22">Stockler MR</searchLink>; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Joshua+AM%22">Joshua AM</searchLink>; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Kinghorn Cancer Centre, St. Vincent's Hospital, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Nguyen+A%22">Nguyen A</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.<br /><searchLink fieldCode="AU" term="%22Emmett+L%22">Emmett L</searchLink>; Department of Theranostics and Nuclear Medicine, St. Vincent's Hospital, Sydney, New South Wales, Australia; louise.emmett@svha.org.au.; St. Vincent's Clinical School, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2023 Mar; Vol. 64 (3), pp. 410-415. <i>Date of Electronic Publication: </i>2022 Sep 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36215568
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.122.264677
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 410
    Titles:
      – TitleFull: 177Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing 177Lu-PSMA-I&T Therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: John N
      – PersonEntity:
          Name:
            NameFull: Pathmanandavel S
      – PersonEntity:
          Name:
            NameFull: Crumbaker M
      – PersonEntity:
          Name:
            NameFull: Counter W
      – PersonEntity:
          Name:
            NameFull: Ho B
      – PersonEntity:
          Name:
            NameFull: Yam AO
      – PersonEntity:
          Name:
            NameFull: Wilson P
      – PersonEntity:
          Name:
            NameFull: Niman R
      – PersonEntity:
          Name:
            NameFull: Ayers M
      – PersonEntity:
          Name:
            NameFull: Poole A
      – PersonEntity:
          Name:
            NameFull: Hickey A
      – PersonEntity:
          Name:
            NameFull: Agrawal S
      – PersonEntity:
          Name:
            NameFull: Perkins G
      – PersonEntity:
          Name:
            NameFull: Kallinen A
      – PersonEntity:
          Name:
            NameFull: Eslick E
      – PersonEntity:
          Name:
            NameFull: Stockler MR
      – PersonEntity:
          Name:
            NameFull: Joshua AM
      – PersonEntity:
          Name:
            NameFull: Nguyen A
      – PersonEntity:
          Name:
            NameFull: Emmett L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1